Clinical Trials List
Protocol NumberUMC119-06-05-FS-01
Completed
2021-04-01 - 2023-12-31
Phase I
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6~12 participants
-
Global
0 participants
